Rokos Capital Management (UK)’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Rokos Capital Management (UK)’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-123,363	Closed	-$2.32M	–	131
2021 Q3	$2.32M	Buy	123,363 +93,363	+311%	+$1.88M	0.05%	56
2021 Q2	$641K	Sell	30,000 -270,000	-90%	-$5.49M	0.01%	110
2021 Q1	$5.79M	Buy	+300,000	New	+$5.29M	0.09%	49

Other funds holding OCDX

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Rokos Capital Management (UK)'s OCDX Position: Q4 2021 in Review

Rokos Capital Management (UK) sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q4 2021, closing a stake of 123,363 shares — an estimated $2.32M sold.

Rokos Capital Management (UK) first reported a position in OCDX in Q1 2021 and held it in 3 quarters. The position peaked at $5.79M in Q1 2021. 162 funds tracked by Wall St. Rank hold OCDX as of Q4 2021.

Rokos Capital Management (UK) reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q4 2021 after selling out during the quarter.
Rokos Capital Management (UK) sold 123,363 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q4 2021, an estimated $2.32M.
Rokos Capital Management (UK) first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 3 quarters.
Rokos Capital Management (UK)'s Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $5.79M in Q1 2021.
162 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q4 2021.

Based on Rokos Capital Management (UK)'s 13F filing for Q4 2021, filed 14 Feb 2022.